Skip to main content
Log in

Diclofenac Reduces the Incidence of AcutePancreatitis After Endoscopic Retrograde Cholangiopancreatography

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Murray B, Carter R, Imrie C, et al.: Diclofenac reduces the indicence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 124:1786–1791, 2003

    Article  CAS  PubMed  Google Scholar 

  2. Mallery JS, Baron TH, Dominitz JA, et al.: Complications of ERCP. Gastrointest Endosc 57:633–638, 2003

    Article  PubMed  Google Scholar 

  3. Loperfido S, Angelini G, Benedetti G, et al.: Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1–10, 1998

    CAS  PubMed  Google Scholar 

  4. Masci E, Toti G, Mariani A, et al.: Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96:417–423, 2001

    Article  CAS  PubMed  Google Scholar 

  5. Freeman ML, DiSario JA, Nelson DB, et al.: Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Gastrointest Endosc 54:425–434, 2001

    Article  CAS  PubMed  Google Scholar 

  6. Barthet M, Lesavre N, Desjeux A, et al.: Complications of endoscopic sphincterotomy: results from a single tertiary referral center. Endoscopy 34:991–997, 2002

    Article  CAS  PubMed  Google Scholar 

  7. Andriulli A, Leandro G, Niro G, et al.: Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51:1–7, 2000

    CAS  PubMed  Google Scholar 

  8. Andriulli A, Clemente R, Teruzzi V, et al.: Gabexate or somatostatin administration before ERCP in patients at high-risk for post-ERCP pancreatitis: a multicenter placebo-controlled randomized clinical trial. Gastrointest Endosc 56:488–495, 2002

    Article  PubMed  Google Scholar 

  9. Binmoeller KF, Harris AG, Dumas R, et al.: Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 33:1129–1133, 1992

    CAS  PubMed  Google Scholar 

  10. Arcidiacono R, Gambitta P, Rossi A, et al.: The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy. Endoscopy 26:715–718, 1994

    Article  CAS  PubMed  Google Scholar 

  11. Deviere J, Le Moine O, van Laethem JL, et al.: Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120:498–505, 2001

    CAS  PubMed  Google Scholar 

  12. Sudhindran S, Bromwich E, Edwards PR: Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 88:1178–1182, 2001

    CAS  PubMed  Google Scholar 

  13. Moreto M, Zaballa M, Casado I, et al.: Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 57:1–7, 2003

    PubMed  Google Scholar 

  14. Dumot JA, Conwell DL, Zuccaro G, et al.: A randomized double blind study of interleukin-10 for prevention of ERCP-induced pancreatitis. Am J Gastroenterol 96:2098–2102, 2001

    CAS  PubMed  Google Scholar 

  15. Rabenstein T, Roggenbuck S, Framke B, et al.: Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 55:476–483, 2002

    PubMed  Google Scholar 

  16. Tarnasky PR, Palesch YK, Cunningham JT, et al.: Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 115:1518–1524, 1998

    CAS  PubMed  Google Scholar 

  17. Fazel A, Quadri A, Catalano MF, et al.: Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57:291–294, 2003

    PubMed  Google Scholar 

  18. Freeman ML: Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents? Gastroenterology 124:1977–1980, 2003 [editorial]

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Madanick, R.D., O’loughlin, C.J. & Barkin, J.S. Diclofenac Reduces the Incidence of AcutePancreatitis After Endoscopic Retrograde Cholangiopancreatography. Dig Dis Sci 50, 879–881 (2005). https://doi.org/10.1007/s10620-005-2658-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2658-x

Keywords

Navigation